Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119743

Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

F Delaunay, A Khan, A Cintra, B Davani, Z C Ling, A Andersson, C G Ostenson, J Gustafsson, S Efendic, and S Okret

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Delaunay, F. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Khan, A. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Cintra, A. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Davani, B. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Ling, Z. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Andersson, A. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Ostenson, C. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Gustafsson, J. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Efendic, S. in: JCI | PubMed | Google Scholar

Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. frde@thon.csb.ki.se

Find articles by Okret, S. in: JCI | PubMed | Google Scholar

Published October 15, 1997 - More info

Published in Volume 100, Issue 8 on October 15, 1997
J Clin Invest. 1997;100(8):2094–2098. https://doi.org/10.1172/JCI119743.
© 1997 The American Society for Clinical Investigation
Published October 15, 1997 - Version history
View PDF
Abstract

Abnormalities contributing to the pathogenesis of non-insulin-dependent diabetes mellitus include impaired beta cell function, peripheral insulin resistance, and increased hepatic glucose production. Glucocorticoids are diabetogenic hormones because they decrease glucose uptake and increase hepatic glucose production. In addition, they may directly inhibit insulin release. To evaluate that possible role of glucocorticoids in beta cell function independent of their other effects, transgenic mice with an increased glucocorticoid sensitivity restricted to their beta cells were generated by overexpressing the glucocorticoid receptor (GR) under the control of the insulin promoter. Intravenous glucose tolerance tests showed that the GR transgenic mice had normal fasting and postabsorptive blood glucose levels but exhibited a reduced glucose tolerance compared with their control littermates. Measurement of plasma insulin levels 5 min after intravenous glucose load demonstrated a dramatic decrease in acute insulin response in the GR transgenic mice. These results show that glucocorticoids directly inhibit insulin release in vivo and identify the pancreatic beta cell as an important target for the diabetogenic action of glucocorticoids.

Version history
  • Version 1 (October 15, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts